Hikma’s diversified business delivers resilient H1 performance

Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma®...

Hikma Ventures Participates in USD 44 Million Financing Round for Altibbi...

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

Hikma strengthens US Injectables business through acquisition of Custopharm

Good momentum across all businesses and updated Generics guidance

Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition

Women in Pink campaign pledges to raise awareness onbreast cancer in...

MSD Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational...

COVID-19 Vaccine Adjuvant Potentials of Nichi Glucan Dietary Supplement From Japan

1...567Page 6 of 7

Connect with us

1,828FansLike
210FollowersFollow
1,929FollowersFollow
30SubscribersSubscribe